Norges Bank’s Arcus Biosciences RCUS Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2025
Q1 | – | Sell |
-34,044
| Closed | -$507K | – | 1291 |
|
2024
Q4 | $507K | Buy |
+34,044
| New | +$507K | ﹤0.01% | 1792 |
|
2024
Q3 | – | Sell |
-11,974
| Closed | -$182K | – | 1352 |
|
2024
Q2 | $182K | Sell |
11,974
-67,850
| -85% | -$1.03M | ﹤0.01% | 1918 |
|
2024
Q1 | $1.51M | Hold |
79,824
| – | – | ﹤0.01% | 1761 |
|
2023
Q4 | $1.52M | Hold |
79,824
| – | – | ﹤0.01% | 1821 |
|
2023
Q3 | $1.43M | Hold |
79,824
| – | – | ﹤0.01% | 1859 |
|
2023
Q2 | $1.62M | Hold |
79,824
| – | – | ﹤0.01% | 1888 |
|
2023
Q1 | $1.46M | Buy |
79,824
+47,998
| +151% | +$875K | ﹤0.01% | 1961 |
|
2022
Q4 | $658K | Sell |
31,826
-122,000
| -79% | -$2.52M | ﹤0.01% | 2082 |
|
2022
Q3 | $4.02M | Buy |
153,826
+15,521
| +11% | +$406K | ﹤0.01% | 1803 |
|
2022
Q2 | $3.5M | Buy |
+138,305
| New | +$3.5M | ﹤0.01% | 1827 |
|
2021
Q3 | – | Sell |
-20,000
| Closed | -$549K | – | 2332 |
|
2021
Q2 | $549K | Hold |
20,000
| – | – | ﹤0.01% | 2160 |
|
2021
Q1 | $562K | Hold |
20,000
| – | – | ﹤0.01% | 2083 |
|
2020
Q4 | $519K | Hold |
20,000
| – | – | ﹤0.01% | 2076 |
|
2020
Q3 | $343K | Buy |
+20,000
| New | +$343K | ﹤0.01% | 2098 |
|
2018
Q2 | – | Sell |
-30,000
| Closed | -$463K | – | 2161 |
|
2018
Q1 | $463K | Buy |
+30,000
| New | +$463K | ﹤0.01% | 2094 |
|